| Dr John C Mcamis, MD | |
|
1029 E Lamar Alexander Pkwy, Maryville, TN 37804-5134 | |
| (865) 546-1642 | |
| (865) 305-6195 |
| Full Name | Dr John C Mcamis |
|---|---|
| Gender | Male |
| Speciality | Obstetrics & Gynecology |
| Location | 1029 E Lamar Alexander Pkwy, Maryville, Tennessee |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1548238785 | NPI | - | NPPES |
| 30001231 | Medicaid | TN |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | 13127 (Tennessee) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr John C Mcamis, MD 1932 Alcoa Hwy, 150, Knoxville, TN 37920-1527 Ph: (865) 546-1642 | Dr John C Mcamis, MD 1029 E Lamar Alexander Pkwy, Maryville, TN 37804-5134 Ph: (865) 546-1642 |
News Archive
Two major drug trials conclude there was little risk from a drug aimed at age-related macular degeneration. Yet a Mayo Clinic ophthalmologist began to note something concerning in some of her patients: an increase in pressure inside the eye. It led to a retrospective study and findings that will be presented at the American Academy of Ophthalmology in Orlando.
Pembrolizumab was initially introduced for the treatment of melanoma. Since July 2016, the monoclonal antibody has also been available for the treatment of locally advanced or metastatic non-small cell lung cancer (NSCLC) in adults whose tumours express the T-cell receptor ligand PD-L1 and who have received a prior chemotherapy regimen.
Raptor Pharmaceutical Corp., today announced results from a Phase 2b clinical trial of its proprietary delayed-release cysteamine bitartrate ("DR Cysteamine") in patients with nephropathic cystinosis ("cystinosis"). The trial, conducted at the University of California, San Diego ("UCSD") General Clinical Research Center, evaluated safety, tolerability, pharmacokinetics and pharmacodynamics of a single dose of DR Cysteamine in nine cystinosis patients.
They have found that prolactin, a pituitary hormone that normally stimulates breast development and milk production, initiates a new "signaling pathway" that may regulate the growth and survival of breast cancer cells.
Men with high total cholesterol are much more likely to develop high blood pressure than men with low total cholesterol, according to a study in Hypertension: Journal of the American Heart Association.
› Verified 5 days ago
Gary Merlin Mason, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1503 E Lamar Alexander Pkwy, Maryville, TN 37804 Phone: 865-980-5290 Fax: 865-980-5295 | |
Samuel Dixie Evans, M.D. Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 907 E Lamar Alexander Pkwy, Maryville, TN 37804 Phone: 865-981-2155 | |
Nancy F Garza, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 250 Cherokee Professional Park, Maryville, TN 37804 Phone: 865-681-0103 Fax: 865-681-9840 | |
Ms. Tasheema Lanell Fair, M.D Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 250 Cherokee Professional Park, Maryville, TN 37804 Phone: 865-681-0103 | |
Patrick L Morgan, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 270 Bmh Physicians Office Building, Maryville, TN 37804 Phone: 865-546-1642 Fax: 865-681-7949 | |
Annalysa M Johnson, D.O. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 270 Bmh Physicians Office Building, Maryville, TN 37804 Phone: 865-546-1642 Fax: 865-681-7949 | |
Elizabeth D Lebrun, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 1033 E Lamar Alexander Pkwy, Maryville, TN 37804 Phone: 865-681-0103 Fax: 865-681-9840 |